MO

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 1997, for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria). The Company operates primarily in consumer products (Tobacco, Food, Beer) and financial services/real estate. All share and per-share data have been restated to reflect a three-for-one stock split declared on February 26, 1997.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 4.2% ($726 million) driven by higher domestic and international tobacco revenues and North American food revenues, partially offset by declines in international food and beer.
• Profitability: Operating income rose 11.5% ($337 million) and Net Earnings increased 13.3%. Earnings per share grew 15.9% due to higher net earnings and a reduction in weighted average shares outstanding (2,429 million vs. 2,489 million) from share repurchases.
• Segment Performance:
  • Tobacco: Revenues up 8.5% and Operating Income up 12.9%. International tobacco volume grew 8.5% due to acquisitions (Tabaqueira in Portugal, ZPT-Krakow in Poland) and favorable volume/mix, though currency movements reduced income by $84 million.
  • Food: North American food revenues up 5.0% on volume gains in frozen pizza, cereals, and coffee. International food revenues declined 4.9% due to currency headwinds and divestitures.
  • Beer: Revenues declined 10.4% due to lower volume and unfavorable price/mix, though operating income increased slightly due to cost reductions.
• Capital Allocation: The Company repurchased 16.4 million shares for $675 million, completing its $6.0 billion repurchase program. A new $8.0 billion three-year repurchase program was approved. Dividends were increased to $0.40 per share.

Outlook, Risks, and Contingencies

• Legal and Regulatory Risks: The Company faces extensive litigation regarding smoking and health, including approximately 191 individual cases and 25 class actions in the U.S., plus 29 health care cost recovery actions by state and local governments. Plaintiffs seek damages ranging into billions of dollars. Management states it is unable to estimate the potential loss but believes it has valid defenses.
• FDA Regulations: The FDA issued final regulations asserting jurisdiction over cigarettes as "drugs" or "medical devices." A U.S. district court ruled in April 1997 that the FDA has jurisdiction but lacks authority to restrict advertising; the implementation of regulations was stayed pending appeal. The outcome remains uncertain.
• Legislative Resolution: The Company is in discussions with state attorneys general and plaintiffs for a comprehensive legislative resolution. Such a resolution could require an upfront payment of several billion dollars and annual payments of billions, alongside major marketing and regulatory changes, which would materially adversely affect financial position and future revenues.
• Foreign Tax Assessments: Italian tax authorities have asserted assessments of approximately $2.7 billion in taxes and $6.3 billion in interest/penalties for years 1987–1995. The Company is vigorously contesting these claims.
• Currency: The strengthening of the U.S. dollar, particularly against the Japanese yen and European currencies, negatively impacted operating income by $84 million in Q1 1997 and is expected to continue having an unfavorable impact in 1997.

Investor Verification Checklist

• Share Count: Verify that all per-share data is adjusted for the 3-for-1 stock split effective April 10, 1997.
• Debt Levels: Confirm the increase in total debt to $16.3 billion and the debt-to-equity ratio of 1.18.
• Litigation Exposure: Review the status of the 29 health care cost recovery actions and the potential financial impact of a comprehensive legislative settlement.
• FDA Litigation: Monitor the appeal process regarding the FDA's authority to regulate cigarettes and the potential for future advertising restrictions.
• Italian Tax Dispute: Track the outcome of the Italian tax court hearing scheduled for July 1, 1997, regarding the $9 billion+ assessment.
• Share Repurchase Program: Note the completion of the $6.0 billion program and the initiation of the new $8.0 billion program.